The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer
Authors
Keywords
SLC1A5, SLC7A5, SLC3A2, Clusters, Breast cancer, Prognosis
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-24
DOI
10.1007/s10549-018-05111-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes
- (2018) Rokaya El Ansari et al. BRITISH JOURNAL OF CANCER
- Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations
- (2017) Rokaya El Ansari et al. HISTOPATHOLOGY
- Oncogenic MYC Activates a Feedforward Regulatory Loop Promoting Essential Amino Acid Metabolism and Tumorigenesis
- (2017) Ming Yue et al. Cell Reports
- Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol
- (2017) David Dickens et al. Scientific Reports
- MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
- (2016) Andrew R Green et al. BRITISH JOURNAL OF CANCER
- Hypothyroidism and hyperthyroidism and breast cancer risk: a nationwide cohort study
- (2016) Mette Søgaard et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Clinicopathological significance of LAT1 and ASCT2 in patients with surgically resected esophageal squamous cell carcinoma
- (2016) Hiroaki Honjo et al. JOURNAL OF SURGICAL ONCOLOGY
- Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
- (2016) Yujun Hao et al. Nature Communications
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- Amino Acid Transporters in Cancer and Their Relevance to "Glutamine Addiction": Novel Targets for the Design of a New Class of Anticancer Drugs
- (2015) Y. D. Bhutia et al. CANCER RESEARCH
- Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer
- (2015) Mohamed Hassanein et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development
- (2015) Qian Wang et al. JOURNAL OF PATHOLOGY
- ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
- (2015) M van Geldermalsen et al. ONCOGENE
- Expression of Amino Acid Transporters (LAT1 and ASCT2) in Patients with Stage III/IV Laryngeal Squamous Cell Carcinoma
- (2015) Osamu Nikkuni et al. PATHOLOGY & ONCOLOGY RESEARCH
- Differential regulation of mTORC1 by leucine and glutamine
- (2015) J. L. Jewell et al. SCIENCE
- Prognostic significance of amino-acid transporter expression (LAT1, ASCT2 and xCT) in surgically resected tongue cancer
- (2014) M Toyoda et al. BRITISH JOURNAL OF CANCER
- Regulation of mTORC1 by amino acids
- (2014) Liron Bar-Peled et al. TRENDS IN CELL BIOLOGY
- Microarray-based detection and expression analysis of ABC and SLC transporters in drug-resistant ovarian cancer cell lines
- (2013) Radosław Januchowski et al. BIOMEDICINE & PHARMACOTHERAPY
- A new genome-driven integrated classification of breast cancer and its implications
- (2013) Sarah-Jane Dawson et al. EMBO JOURNAL
- Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer
- (2013) Sewha Kim et al. ENDOCRINE-RELATED CANCER
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior
- (2013) Marina Poettler et al. Molecular Cancer
- Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation
- (2013) Linda V Sinclair et al. NATURE IMMUNOLOGY
- ATF4 Regulates MYC-Mediated Neuroblastoma Cell Death upon Glutamine Deprivation
- (2012) Guoliang Qing et al. CANCER CELL
- c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells
- (2012) KEITARO HAYASHI et al. ONCOLOGY REPORTS
- Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis
- (2011) Mio Furuya et al. CANCER SCIENCE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients
- (2010) Daniele Soria et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
- Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer
- (2010) KYOICHI KAIRA et al. Experimental and Therapeutic Medicine
- l-Type amino acid transporter 1 inhibitors inhibit tumor cell growth
- (2009) Koji Oda et al. CANCER SCIENCE
- L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas
- (2009) Kyoichi Kaira et al. JOURNAL OF SURGICAL ONCOLOGY
- Prognostic significance of l-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma
- (2009) Kyoichi Kaira et al. LUNG CANCER
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
- (2009) Ping Gao et al. NATURE
- Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
- (2009) R J DeBerardinis et al. ONCOGENE
- Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung
- (2008) Kyoichi Kaira et al. CANCER SCIENCE
- Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung
- (2008) Kyoichi Kaira et al. PATHOLOGY RESEARCH AND PRACTICE
- Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
- (2008) D. R. Wise et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started